Cargando…

Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis

Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are two types of chronic cholestatic liver disease (CCLD). Little is known regarding the relationship between these conditions and pregnancy. We performed a systematic review and meta-analysis regarding the maternal and fetal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrigno, Bryan, Barba, Romelia, Medina-Morales, Esli, Trivedi, Hirsh, Patwardhan, Vilas, Bonder, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875982/ https://www.ncbi.nlm.nih.gov/pubmed/35207342 http://dx.doi.org/10.3390/jcm11041068

Ejemplares similares

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
por: Barba Bernal, Romelia, et al.
Publicado: (2023)

Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases
por: Nsubuga, John Paul, et al.
Publicado: (2021)

Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points
por: Goyes, Daniela, et al.
Publicado: (2021)

Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023)

Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations
por: Medina-Morales, Esli, et al.
Publicado: (2023)

New OPTN Simultaneous Liver-Kidney Transplant (SLKT) Policy Improves Racial and Ethnic Disparities
por: Goyes, Daniela, et al.
Publicado: (2020)

Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis
por: Freedman, Benjamin L., et al.
Publicado: (2020)

Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease
por: Suri, Jaspreet S., et al.
Publicado: (2020)

Hemostasis, bleeding and thrombosis in liver disease
por: Flores, Brisas, et al.
Publicado: (2017)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists
por: Trivedi, Palak J., et al.
Publicado: (2015)

Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
por: Reardon, Jillian, et al.
Publicado: (2016)

Systematic review: efficacy of therapies for cholestatic pruritus
por: Ebhohon, Ebehiwele, et al.
Publicado: (2023)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges
por: Trivedi, Hirsh D, et al.
Publicado: (2020)

Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta-Analysis
por: Ma, Xiao, et al.
Publicado: (2014)

Chronic Cholestatic Liver Injury Attributable to Vedolizumab
por: Stine, Jonathan G., et al.
Publicado: (2016)

Cellular crosstalk during cholestatic liver injury
por: Thomson, Joanne, et al.
Publicado: (2017)

Cholestatic liver diseases: An era of emerging therapies
por: Samant, Hrishikesh, et al.
Publicado: (2019)

The Role of Vitamin K in Cholestatic Liver Disease
por: Sultana, Halima, et al.
Publicado: (2021)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021)

Guidelines for the Management of Cholestatic Liver Diseases (2021)
por: Lu, Lungen
Publicado: (2022)

Human Hepatocellular response in Cholestatic Liver Diseases
por: Ortiz, Kimberly, et al.
Publicado: (2023)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

DNA methylation profile of liver tissue in end-stage cholestatic liver disease
por: Cheung, Angela C, et al.
Publicado: (2022)

Signals for Hepatic Figrogenesis in Pediatric Cholestatic Liver Disease: Review and Hypothesis
por: Ramm, Grant A, et al.
Publicado: (2004)

Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma
por: Virani, Shohaib, et al.
Publicado: (2018)

The Role of Liver Biopsy in Investigation of Cholestatic Liver Disease in Infancy
por: Chaudhry, Zoya, et al.
Publicado: (2019)

Ileal Bile Acid Transporter Blockers for Cholestatic Liver Disease in Pediatric Patients with Alagille Syndrome: A Systematic Review and Meta-Analysis
por: Muntaha, Hafiza Sidra tul, et al.
Publicado: (2022)

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy
por: Heerkens, Marieke, et al.
Publicado: (2019)

Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis
por: DERVOUT, Charles, et al.
Publicado: (2022)

Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
por: Halilbasic, Emina, et al.
Publicado: (2013)

Recent developments in the management of idiopathic cholestatic liver disease
por: Imam, Mohamad H., et al.
Publicado: (2012)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Current and future therapies for inherited cholestatic liver diseases
por: van der Woerd, Wendy L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ughc1eegbvcfoi24u6ntjdbkca